NOVEL MEMBRANE-PROTEINS PRESENT IN TEICOPLANIN-RESISTANT, VANCOMYCIN-SENSITIVE, COAGULASE-NEGATIVE STAPHYLOCOCCUS SPP

被引:33
作者
OHARE, MD
REYNOLDS, PE
机构
[1] UNIV COLL HOSP LONDON,DEPT CLIN MICROBIOL,WC1 LONDON,ENGLAND
[2] UNIV CAMBRIDGE,DEPT BIOCHEM,TENNIS COURT RD,CAMBRIDGE CB2 1QW,ENGLAND
关键词
D O I
10.1093/jac/30.6.753
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Clinical isolates of Staphylococcus epidermids and Staphylococcus haemolyticus resistant to teicoplanin (MIC 64 mg/L) and sensitive to vancomycin (MIC 2 mg/L), were compared with vancomycin- and teicoplanin-sensitive isolates (MICs I mg/L) of the same species. No apparent differences between the sensitive and resistant strains of either pair were found with respect to binding of teicoplanin to the bacteria, or to the amino acid content or degree of cross-linkage of purified peptidoglycan. The resistant strains did not inactivate teicoplanin in the surrounding medium. Analysis of the membrane proteins of the resistant S. epidermidis strain grown in the presence or absence of sub-inhibitory levels of teicoplanin (4 mg/L), showed the presence of a 39 kDa protein which was either absent, or present in considerably reduced amounts, in the sensitive strain. Fractionation of cell components after lysis of protoplasts showed that the 39 kDa protein was present predominantly in the membrane fraction but also in small amounts in the wall fraction. Similar investigations with S. haemolyticus revealed the presence of a 35 kDa protein in membranes of the resistant strain: the amount was increased substantially by growth in sub-inhibitory levels of teicoplanin. Membranes prepared by mechanical disintegration of bacteria or by osmotic lysis of protoplasts showed large apparent differences in the amounts of the 39 kDa protein. © 1992 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:753 / 768
页数:16
相关论文
共 31 条
[1]   MECHANISM OF RESISTANCE TO VANCOMYCIN IN ENTEROCOCCUS-FAECIUM D366 AND ENTEROCOCCUS-FAECALIS A256 [J].
ALOBEID, S ;
COLLATZ, E ;
GUTMANN, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) :252-256
[2]   EVIDENCE FOR INVIVO INCORPORATION OF D-LACTATE INTO PEPTIDOGLYCAN PRECURSORS OF VANCOMYCIN-RESISTANT ENTEROCOCCI [J].
ARTHUR, M ;
MOLINAS, C ;
BUGG, TDH ;
WRIGHT, GD ;
WALSH, CT ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :867-869
[3]   THE VANS-VANR 2-COMPONENT REGULATORY SYSTEM CONTROLS SYNTHESIS OF DEPSIPEPTIDE PEPTIDOGLYCAN PRECURSORS IN ENTEROCOCCUS-FAECIUM BM4147 [J].
ARTHUR, M ;
MOLINAS, C ;
COURVALIN, P .
JOURNAL OF BACTERIOLOGY, 1992, 174 (08) :2582-2591
[4]   THE STRUCTURE AND MODE OF ACTION OF GLYCOPEPTIDE ANTIBIOTICS OF THE VANCOMYCIN GROUP [J].
BARNA, JCJ ;
WILLIAMS, DH .
ANNUAL REVIEW OF MICROBIOLOGY, 1984, 38 :339-357
[5]   VANCOMYCIN ADSORPTION TO BACILLUS SUBTILIS CELL WALLS [J].
BEST, GK ;
DURHAM, NN .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1965, 111 (03) :685-&
[6]   IDENTIFICATION OF VANCOMYCIN RESISTANCE PROTEIN VANA AS A D-ALANINE - D-ALANINE LIGASE OF ALTERED SUBSTRATE-SPECIFICITY [J].
BUGG, TDH ;
DUTKAMALEN, S ;
ARTHUR, M ;
COURVALIN, P ;
WALSH, CT .
BIOCHEMISTRY, 1991, 30 (08) :2017-2021
[7]   MOLECULAR-BASIS FOR VANCOMYCIN RESISTANCE IN ENTEROCOCCUS-FAECIUM BM4147 - BIOSYNTHESIS OF A DEPSIPEPTIDE PEPTIDOGLYCAN PRECURSOR BY VANCOMYCIN RESISTANCE PROTEINS VANH AND VANA [J].
BUGG, TDH ;
WRIGHT, GD ;
DUTKAMALEN, S ;
ARTHUR, M ;
COURVALIN, P ;
WALSH, CT .
BIOCHEMISTRY, 1991, 30 (43) :10408-10415
[8]   COMPARISON OF THE SOLID-PHASE ENZYME RECEPTOR ASSAY (SPERA) AND THE MICROBIOLOGICAL ASSAY FOR TEICOPLANIN [J].
CAVENAGHI, L ;
CORTI, A ;
CASSANI, G .
JOURNAL OF HOSPITAL INFECTION, 1986, 7 :85-89
[9]   VANCOMYCIN-RESISTANT LEUCONOSTOCS, LACTOBACILLI AND NOW PEDIOCOCCI [J].
COLMAN, G ;
EFSTRATIOU, A .
JOURNAL OF HOSPITAL INFECTION, 1987, 10 (01) :1-3
[10]   PHENOTYPIC AND GENOTYPIC HETEROGENEITY OF GLYCOPEPTIDE RESISTANCE DETERMINANTS IN GRAM-POSITIVE BACTERIA [J].
DUTKAMALEN, S ;
LECLERCQ, R ;
COUTANT, V ;
DUVAL, J ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (10) :1875-1879